Study on the Intervention Effect of Denosumab on High-Risk Patients With Osteoporotic Fractures in Type 2 Diabetes

NCT07063797 · clinicaltrials.gov ↗

NA

Phase

NOT_YET_RECRUITING

Status

358

Enrollment

OTHER

Sponsor class

Conditions

Type 2 Diabetes
Osteoporosis
Fractures

Interventions

DRUG: Denosumab treatment in type 2 diabetes mellitus (T2DM) with osteoporosis patients
DRUG: Denosumab combined with eldecalcitol treatment in type 2 diabetes mellitus (T2DM) with osteoporosis patients

Sponsor

Peking Union Medical College Hospital